Evidence map›Paper›PMID 37027179›Full record

ArticleThe Journal of experimental medicine2023

Age-related alterations in meningeal immunity drive impaired CNS lymphatic drainage.

Justin Rustenhoven, Georgios Pavlou, Steffen E Storck, Taitea Dykstra, Siling Du, Zhengpeng Wan, Daniel Quintero, Joshua P Scallan, Igor Smirnov, Roger D Kamm and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Justin RustenhovenBrain Immunology and Glia Center, School of Medicine, Washington University in St. Louis , St. Louis, MO, USA.ORCID 0000-0002-9376-7424
Georgios Pavlou *Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0003-0236-1953
Steffen E Storck *Brain Immunology and Glia Center, School of Medicine, Washington University in St. Louis , St. Louis, MO, USA.ORCID 0000-0002-6965-2264
Taitea DykstraBrain Immunology and Glia Center, School of Medicine, Washington University in St. Louis , St. Louis, MO, USA.ORCID 0000-0001-7756-809X
Siling DuBrain Immunology and Glia Center, School of Medicine, Washington University in St. Louis , St. Louis, MO, USA.ORCID 0000-0003-1540-3585
Zhengpeng WanDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0001-5626-7722
Daniel QuinteroBrain Immunology and Glia Center, School of Medicine, Washington University in St. Louis , St. Louis, MO, USA.ORCID 0000-0001-8243-7107
Joshua P ScallanDepartment of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA.ORCID 0000-0002-1190-7308
Igor SmirnovBrain Immunology and Glia Center, School of Medicine, Washington University in St. Louis , St. Louis, MO, USA.ORCID 0000-0003-2373-6742
Roger D KammDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.ORCID 0000-0002-7232-304X
Jonathan KipnisBrain Immunology and Glia Center, School of Medicine, Washington University in St. Louis , St. Louis, MO, USA.ORCID 0000-0002-3714-517X
Washington University in St. Louis · USMassachusetts Institute of Technology · USUniversity of Auckland · NZUniversity of South Florida · US

Funding

Immune system supports brain functionR37AG034113 · NIA · WASHINGTON UNIVERSITY · PI Jonathan Kipnis · 2020 to 2026
$3.7M
Robust workflow software for MRI tracking of glymphatic-lymphatic couplingR01AT011419 · NCCIH · YALE UNIVERSITY · PI BENVENISTE, HELENE D, KIPNIS, JONATHAN · 2021 to 2025
$3.6M
Aged T-cell-derived cytokines impact meningeal lymphatics and contribute to ADR01AG078667 · NIA · WASHINGTON UNIVERSITY · PI Jonathan Kipnis · 2022 to 2026
$2.9M
VEGFR Signaling Controls Lymphatic JunctionsR01HL164825 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI SCALLAN, JOSHUA PAUL · 2022 to 2025
$2.6M
Human 3D Neuro-Vascular Interaction and Meningeal Lymphatic Models with Application to Alzheimer’s DiseaseR01NS121078 · NINDS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI CHOI, SE HOON, JORFI, MEHDI · 2021 to 2025
$2.6M
Pathways Regulating Lymphatic Vessel Permeability and Valve FormationR01HL142905 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI SCALLAN, JOSHUA PAUL · 2019 to 2023
$2.2M
NCCIH NIH HHS R01 AT011419NHLBI NIH HHS R01 HL142905NHLBI NIH HHS R01 HL164825NIA NIH HHS R01 AG078667NIA NIH HHS R37 AG034113NINDS NIH HHS R01 NS121078
6 · The paper itself

Abstract

The meningeal lymphatic network enables the drainage of cerebrospinal fluid (CSF) and facilitates the removal of central nervous system (CNS) waste. During aging and in Alzheimer's disease, impaired meningeal lymphatic drainage promotes the buildup of toxic misfolded proteins in the CNS. Reversing this age-related dysfunction represents a promising strategy to augment CNS waste clearance; however, the mechanisms underlying this decline remain elusive. Here, we demonstrate that age-related alterations in meningeal immunity underlie this lymphatic impairment. Single-cell RNA sequencing of meningeal lymphatic endothelial cells from aged mice revealed their response to IFNγ, which was increased in the aged meninges due to T cell accumulation. Chronic elevation of meningeal IFNγ in young mice via AAV-mediated overexpression attenuated CSF drainage-comparable to the deficits observed in aged mice. Therapeutically, IFNγ neutralization alleviated age-related impairments in meningeal lymphatic function. These data suggest manipulation of meningeal immunity as a viable approach to normalize CSF drainage and alleviate the neurological deficits associated with impaired waste removal.

Indexed as

Alzheimer DiseaseLymphatic VesselsAnimalsBrainCentral Nervous SystemEndothelial CellsLymphatic SystemMeningesMice

Identifiers

PMID37027179
PMCPMC10083715
OpenAlexW4362692201

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.